Understanding these variables helps set realistic expectations and optimize therapeutic outcomes
In receptor-based analyses, the GLP-1 pathway is primarily examined in relation to the regulation of glucose-dependent insulin secretion, the inhibition of glucagon signalling, and mechanisms involved in appetite control
doi: 10.1016/j.neuropharm.2014.04.007 100 CuiSSFengXBZhangBHXiaZYZhanLY
Its first-mover advantage, combined with strong reimbursement coverage in major developed markets, has made it the reference molecule for obesity pharmacotherapy
The LEADER trial [17] was the first with a long-acting agonist (liraglutide provides a varying but relevant 24-hour exposure)
If patients are looking at a $499-or-higher price tag, you might as well say it costs a million dollars a month, because theyre not going to access it. The ad features a New Yorker -styled comic strip, in which two employees at the Department of Health and Human Services (HHS) are holding a lengthy High-Priced Drug List. It would have been quicker to make a low-priced drug list, the punchline quips